The Precision Nutrition and Cancer laboratory, headed by Dr. Ramirez de Molina focuses on improving the quality of life of cancer patients by designing precision nutrition products and strategies to improve tumor treatment and prognosis, as well as nutritional strategies to improve immune system impairment. The Precision Nutrition group is focused on studying the relationship between precision nutrition, metabolism and cancer. His group develops multidisciplinary research focused on: exploring metabolic reprogramming as a biomarker and therapeutic target in cancer; the study of the relationship between lifestyle factors (nutrition, physical activity), genetics (individual susceptibility), the consequent global metabolic state (healthy/unhealthy), its relationship with chronic inflammation and immune response, and the development, progression and response to treatment of cancer patients.

He is also involved in the development and application of digital systems and mhealth platforms to enable the exchange of key clinical prognostic data (patient symptoms, genetics, nutritional lifestyle factors…) between oncologists and patients, which are improving medical decision making by optimizing cancer treatment. In short, its main objective is to include precision nutrition in personalized medicine by analyzing personal characteristics, genetic susceptibility and physiological conditions, the microbiome, etc. to define biomarkers and personalized nutritional strategies that are effective in promoting health through molecular nutrition.